Your browser doesn't support javascript.
loading
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.
Tay, Apple Hui Min; Prieto-Díaz, Rubén; Neo, Shiyong; Tong, Le; Chen, Xinsong; Carannante, Valentina; Önfelt, Björn; Hartman, Johan; Haglund, Felix; Majellaro, Maria; Azuaje, Jhonny; Garcia-Mera, Xerardo; Brea, Jose M; Loza, Maria I; Jespers, Willem; Gutierrez-de-Teran, Hugo; Sotelo, Eddy; Lundqvist, Andreas.
Afiliação
  • Tay AHM; Department of Biological Science, Nanyang Technological University, Singapore.
  • Prieto-Díaz R; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Neo S; Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain.
  • Tong L; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Chen X; Singapore Immunology Network SIgN, Agency for Science, Technology and Research, Singapore, Republic of Singapore.
  • Carannante V; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Önfelt B; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Hartman J; Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Haglund F; Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Majellaro M; Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Azuaje J; Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Garcia-Mera X; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Brea JM; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Loza MI; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Jespers W; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Gutierrez-de-Teran H; Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain.
  • Sotelo E; Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain.
  • Lundqvist A; Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain.
J Immunother Cancer ; 10(5)2022 05.
Article em En | MEDLINE | ID: mdl-35580926

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores Purinérgicos P1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores Purinérgicos P1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article